These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15394581)

  • 1. Investigations on haemophilia VIII, plasma transfusions in haemophilia.
    VAN CREVELD S; PAULSSEN MM
    Acta Brevia Neerl Physiol Pharmacol Microbiol E A; 1949; 17(1-4):1-9, pl. PubMed ID: 15394581
    [No Abstract]   [Full Text] [Related]  

  • 2. PLASMA TRANSFUSIONS IN HAEMOPHILIA.
    BRADLOW BA
    Br Med J; 1965 Mar; 1(5438):859. PubMed ID: 14258858
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case of hemophilia resistant to blood and plasma transfusions].
    CROKAERT J; HOLLENDER L
    Brux Med; 1951 Feb; 31(5):252-7. PubMed ID: 14812155
    [No Abstract]   [Full Text] [Related]  

  • 4. TRANSFUSIONS IN HAEMOPHILIA.
    BRITTEN A
    Br Med J; 1965 May; 1(5443):1186. PubMed ID: 14273530
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasma transfusions in hemophiliacs].
    VAN CREVELD S; PAULSSEN MM
    Ned Tijdschr Geneeskd; 1949 Oct; 93(44):3714-23. PubMed ID: 15407345
    [No Abstract]   [Full Text] [Related]  

  • 6. [PLASMA TRANSFUSION IN HEMOPHILIA. IX. EXPERIENCE WITH 2-DONOR FIBRINOGEN].
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Ned Tijdschr Geneeskd; 1963 Sep; 107():1736-9. PubMed ID: 14050958
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma transfusions in hemophilia.
    VAN CREVELD S; PAULSSEN MM
    Blood; 1952 Jul; 7(7):710-20. PubMed ID: 14934756
    [No Abstract]   [Full Text] [Related]  

  • 8. [PLASMA TRANSFUSIONS IN HEMOPHILIA (X). EXPERIENCES WITH LYOPHILIZED 2-DONOR FIBRINOGEN].
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Ned Tijdschr Geneeskd; 1964 Apr; 108():843-4. PubMed ID: 14144908
    [No Abstract]   [Full Text] [Related]  

  • 9. Surgery in haemophilia; the use of animal antihaemophilic globulin and human plasma in thirteen cases.
    MACFARLANE RG; MALLAM PC; WITTS LJ; BIDWELL E; BIGGS R; FRAENKEL GJ; HONEY GE; TAYLOR KB
    Lancet; 1957 Aug; 273(6989):251-9. PubMed ID: 13450386
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma transfusion in hemophilia. VIII. Effect of various plasma products on hemophilia A].
    van CREVELD ; MOCHTAR IA
    Ned Tijdschr Geneeskd; 1963 Jan; 107():155-9. PubMed ID: 14023830
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effect of serum and plasma transfusions on the clotting defect in canine haemophilia B.
    MUSTARD JF; BASSER W; HEDGARDT G; SECORD D; ROWSELL HC; DOWNIE HG
    Br J Haematol; 1962 Jan; 8():36-42. PubMed ID: 14477606
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigation of an outbreak of hepatitis A in Irish haemophilia A patients.
    Lawlor E; Johnson Z; Thornton L; Temperley I
    Vox Sang; 1994; 67 Suppl 1():18-9; discussion 20. PubMed ID: 8091729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of normal human plasma fractions in haemophilia.
    VAN CREVELD S; MASTENBROEK GG
    Nature; 1946 Sep; 158():447. PubMed ID: 20999102
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemophilia management in transfusion medicine.
    Poon MC; Card R
    Transfus Apher Sci; 2012 Jun; 46(3):299-307. PubMed ID: 22503305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product.
    Yee TT; Williams MD; Hill FG; Lee CA; Pasi KJ
    Thromb Haemost; 1997 Sep; 78(3):1027-9. PubMed ID: 9308748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII - clarification of Kogenate inhibitor data.
    Larson P
    Br J Haematol; 2005 Jul; 130(1):145-6; author reply 146-7. PubMed ID: 15982357
    [No Abstract]   [Full Text] [Related]  

  • 18. The history of haemophilia - a short review.
    Schramm W
    Thromb Res; 2014 Nov; 134 Suppl 1():S4-9. PubMed ID: 24513149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis-associated antigen and antibodies after multiple transfusions in children and juveniles with severe and moderately severe haemophilia (author's transl)].
    Schwartz B; Landbeck G
    Dtsch Med Wochenschr; 1973 Oct; 98(43):2016-9. PubMed ID: 4744372
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention and control of haemophilia: memorandum from a joint WHO/WFH meeting (World Federation of Haemophilia).
    Bull World Health Organ; 1991; 69(1):17-26. PubMed ID: 1905206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.